A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery

Bibliographic Details
Published in:	Mediterranean Journal of Hematology and Infectious Diseases
Main Authors:	Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-10-01
Subjects:	Hodgkin Lymphoma Classical Hodgkin lymphoma Nivolumab
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5491

Similar Items

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience
by: K. V. Lepik, et al.
Published: (2019-01-01)

Nivolumab in relapsed/refractory Hodgkin Lymphoma patients, single center experiences
by: Ramazan Acar, et al.
Published: (2020-12-01)

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
by: Valentina Giudice, et al.
Published: (2022-04-01)

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
by: D. D. Ivanova, et al.
Published: (2024-12-01)

PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma
by: EA Demina
Published: (2018-07-01)

Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report
by: Chulmin Park, et al.
Published: (2023-03-01)

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma
by: Lin AY, et al.
Published: (2022-02-01)

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
by: Pezzullo Luca, et al.
Published: (2021-04-01)

Synchronous Lymphomas: An Uncommon Affair
by: Manohor Vidhya
Published: (2020-08-01)

Clinical and Biomarker Characteristic of Lymphoma Patients in Hasan Sadikin Lymphoma Registry
by: Oehadian A, et al.
Published: (2024-08-01)

Hodgkin Lymphoma Mimicking Osteomyelitis
by: Aneela Majeed, et al.
Published: (2017-06-01)

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy
by: Lorenzo Falchi, et al.
Published: (2016-11-01)

Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients
by: Elisa Lucchini, et al.
Published: (2021-06-01)

Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of Nivolumab
by: Bond DA, et al.
Published: (2017-05-01)

Unilateral Ptosis in an Older Adult; a Rare Presentation of Primary Extranodal Hodgkin’s Lymphoma
by: Insija Ilyas Selene, et al.
Published: (2022-02-01)

HIV ASSOCIATED LYMPHOMA – TWO CASE REPORT SERIES
by: Liana-Cătălina Gavriliu, et al.
Published: (2016-09-01)

Lymphoma in Taiwan: Review of 1347 neoplasms from a single institution according to the 2016 Revision of the World Health Organization Classification
by: Shih-Sung Chuang, et al.
Published: (2017-08-01)

Abdominal tumors in children: A comprehensive study on the diagnosis, management, and clinical outcome of pediatric patients with lymphoma in Kashmir
by: Zahida Akhtar, et al.
Published: (2022-11-01)

Anemia in Lymphoma Patients in Indonesia: The Prevalence and Predictive Factors
by: Mardiah Suci Hardianti, et al.
Published: (2021-11-01)

Burden of Anaemia and its Impact on Lymphoma Patients in Southern Rajasthan, India: A Cross-sectional Study
by: Gulshan Kumar Mukhiya, et al.
Published: (2023-11-01)

Isolated gastric involvement of recurrent Hodgkin lymphoma: a case report and review of the literature
by: Soroush Kohansal, et al.
Published: (2023-05-01)

Cyclooxygenase-2(COX-2) Expression in Lymphoma in North-West of Iran
by: Seyyed Hadi Chavoshi, et al.
Published: (2013-01-01)

GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
by: Mani Ramzi, et al.
Published: (2015-03-01)

Cyclooxygenase-2 (COX-2) expression in lymphoma in north-west of Iran
by: Zohreh Sanaat, et al.
Published: (2013-03-01)

Early Radiation-Induced Sarcoma in an Adolescent Treated for Relapsed Hodgkin Lymphoma with Nivolumab
by: Lukas Šalaševičius, et al.
Published: (2020-03-01)

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma
by: Amanda F. Cashen
Published: (2024-10-01)

Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
by: Walter Hanel, et al.
Published: (2022-12-01)

Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France
by: Marie Donzel, et al.
Published: (2022-12-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01)

Comparative global burden analysis of lymphoma subtypes: a statistical evaluation of severity across global regions
by: Yu Liang, et al.
Published: (2025-04-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01)

The Frequency and Clinical Relevance of Multidrug Resistance Protein Expression in Patients with Lymphoma
by: Eren Gündüz, et al.
Published: (2012-05-01)

Global spatiotemporal distributions of lymphoma from 1990 to 2019: A Joinpoint regression analysis based on the global burden of disease study 2019, and projections until 2044
by: Jiacheng Liu
Published: (2024-06-01)

Mortality Rate of Lymphoma in China, 2013–2020
by: Weiping Liu, et al.
Published: (2022-06-01)

Single center experience in patients with a diagnosis of nodular lymphocyte predominant Hodgkin lymphoma
by: Fahir Özkalemkaş, et al.
Published: (2021-03-01)

A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
by: Federico Meconi, et al.
Published: (2020-08-01)

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
by: Mira Romany Massoud, et al.

Serum IL-13 levels at diagnosis and remission in children with malignant lymphoma
by: Derya Özyörük, et al.
Published: (2016-06-01)

Who is WHO and what was REAL?
by: Swiss Medical Weekly
Published: (2002-11-01)